clinical research of the preventive treatment form igrainousvertigo without headanche and observing the evoke dpotential
Abstract
ObJECTive:ToobseRvethepr[Eve]ntivetREATmeNTforpatientswithnon-headachetyPemigRainevertigo.Method:48CAsesoFpatieNTswithnon-HeaDAChetypemIgRaINevertigowereRAndomlyDIvIDeDintotREATmeNTgroupaNDControlgroup.TheTreatmentGroupwasgoingtobetReatedbyflunarizine,anDtheCoNTrolgRouPwasgoingtobetReatedbyBetahIsti\ ne.Allofthemtooka8-weektREATmeNTperioD.SepaRAtelysTudyvisuaLevokedpotentiaLmeasurEmentoFmigRaINePatientswithvertigobeFoReaNDAftertheRapy.Result:8weeKsafteRthetREATmeNT,ThecuRativeeffECToftheTreatmEntgroUPwassignificaNTLybetteRtHatHeControlgroup(X2=27.1888,P[0.01, p a)tieNTsWithvertigoweR[E]RECEivinGProsthEtictReaTmeNT(P"0".1, a n)dthemiGRaineveRtigoPatientsoFUNUsuallyvisuaLevokedpotentiaLsmeasurEswerealsoeaseDAftertReatmenT.ConClusion:ForthePatieNTswithnon-HeaDAChetypemIgRaINevertigo,FlunariZINePreventivetReaTmeNTHasbeTTeRclinicaLcurativeeffECT.
References
NeuhauseRH,leopoldM,vonBREveRn,etal.theinteRReLa-tioNsofmig[]aINe,veRtigoandmigRaINousvertigo[J].Neurol-ogy,$1,56 (4):,6-441.
NeuhauseRHK,RadtkeA,V/onbreveRNM,eTal.MigRainousvertigo:PrEvalenCeandimPactonQualityofLife[J].Neurol-ogy,/6,67 (6):1028-1033.
UonBREveRNM,ZeisED,NeuhauseRH, andetal.Acute"i" (A) (A) () () (+)I-gRaINousvertigo:clinicaLaNDoculographicfindings[J].BRaIN,$5,8(Pt2):5-4,.
WateR[s]oNJ.ChronicmigRainousvertigo[J].ClinneuRosci,4,11 (4):-4-8.
Lempe()T,NeUHauseRH.MigRainousvertiGo[J].NeurolCLin,25,3 (3):,5-,0.
vonBREveRNM,TaN,ShaNKaRA,etAl.MigRainousverti-go:mutationanalysIsofthEcandidateGEnesCACNa1a,aTP1A2,SCN1A,aNDcAcNB4[J].headachE,,6,46(7):1136-1141.
BRandtt.achamelEONamongtheepisodIcvertigosyn-Dromes:'mIgRainousvertigo'or'vestiBULaRmigRaine[J].CePhaLaLgIa,$4,24 (2):81-82.
Copyright (c) 2013 WANG xiangming
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution-Noncommercial 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, that the work is not used for commercial purposes, and that in the event of reuse or distribution, the terms of this license are made clear. With this license, the authors hold the copyright without restrictions and are allowed to retain publishing rights without restrictions as long as this journal is the original publisher of the articles.
